Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.666, 2012-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab gives a boost to chemotherapeutics in mCRC
Inpharma, Vol. 1, Iss. 1603, 2007-01 ,pp. :
Access to resources
Recommend
Topical corticosteroids best value for money in psoriasis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 672, 2013-01 ,pp. :
Atorvastatin best value for money for secondary CHD prevention
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 408-409, 2003-01 ,pp. :
Which antifungal agents best value for money in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 433, 2003-01 ,pp. :
Which antifungal agents best value for money in the US?
Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. :